Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

People with acne have more CD4+ immune cells in their skin than healthy people.

BTNL2 helps protect hair follicles from immune attacks.

Anti-CD19 therapy may help treat SLE and NMOSD.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Enhancing Tregs can protect against alopecia areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Basal cell carcinoma cases are rising globally.

BCC can protect heart cells from damage caused by oxidative stress.